|Last Price||Today's Change||52-Week Range||Trading Volume|
|1.04 CAD||-0.03 (-2.80%)||0.41 - 1.51||136.1 thousand (Below Avg)|
Market data as of 3:59PM 12/18/14. Quotes are delayed by at least 15 min.
Cynapsus Therapeutics Announces Uplisting to the Toronto Stock Exchange’s Senior Equity Market
Business Wire - Tuesday 11/25/2014 4:10 PM ET
Cynapsus Therapeutics Announces Positive Top-Line Results from CTH-105 Phase 2 Study of APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease
Business Wire - Wednesday 11/19/2014 6:00 AM ET
Cynapsus to Announce Top-Line Results from the CTH-105 Phase 2 Study on November 19, 2014
Business Wire - Tuesday 11/18/2014 4:40 PM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.